Atherogenic Index of Plasma Levels in Patients with Diabetic and Neurodiabetic | ||
| kufa Journal for Nursing sciences | ||
| Article 1, Volume 6, Issue 2, August 2016, Pages 29-34 | ||
| Authors | ||
| Zeinab M. Al-Rubaei; Tamara Ala; a Hussein | ||
| Abstract | ||
| Objective: To determined the levels of lipid profile (TC, TG, HDL-c, LDL-C, VLDL) in diabetic and diabetic neuropathy patients and compare the results with control group. Also, to compare Atherogenic Index of Plasma (AIP) levels in these groups that may be predict prone of patients to cardiovascular disease. Methodology: Ninety subjects were enrolled in this study with aged ranged (40-65) years and BMI with (30-35) Kg/m2 that divided into three groups as follows: group one (G1) consists of 30 healthy individuals as a control group, group two (G2) consists of 30 patients with diabetes and group three (G3) consists of 30 patients with diabetes and neuropathy as complication. Electrochemical Skin Conductance (Feet Mean), Electrochemical Skin Conductance (Hand Mean), Electrochemical Skin Conductance (Risk of neuropathies), FBS, TC, TG and HDL-c were determined. Also, LDL-C, VLDL and AIP were calculated. Results: This study illustrated no significant increased were found in TC and LDL in G2 comparing to G1, while there was highly significant increase in TC and LDL in G2 comparing to G3 and in G3 comparing to G1. Results, also, revealed highly significant increase in TG and VLDL in G2 comparing to G1, G2 comparing to G3, and G3 comparing to G1. Data demonstrated highly significant decrease in HDL-c in G2 and G3 comparing to G1, while no significant decrease observed in G3 comparing to G2. Data, also, demonstrated highly significant increase in AIP levels in G2 and G3 comparing to G1, while no significant increased observed in G3 comparing to G2. Conclusion: The study concluded that AIP is elevated in diabetic and neurodiabetic patients who could be used as a marker for predict CVD in patients groups. Recommendation: Study the genetic analysis for wide range patients with diabetic, neurodiabetic and control as a comprehensive surrey. | ||
| Keywords | ||
| diabetic neuropathy; Lipid profile and AIP | ||
|
Statistics Article View: 55 PDF Download: 21 |
||